These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33551769)

  • 1. Assessment of Behavioral Characteristics With Procedures of Minimal Human Interference in the
    Engelbeen S; Aartsma-Rus A; Koopmans B; Loos M; van Putten M
    Front Behav Neurosci; 2020; 14():629043. PubMed ID: 33551769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive flexibility deficits in a mouse model for the absence of full-length dystrophin.
    Remmelink E; Aartsma-Rus A; Smit AB; Verhage M; Loos M; van Putten M
    Genes Brain Behav; 2016 Jul; 15(6):558-67. PubMed ID: 27220066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive dysfunction in the dystrophin-deficient mouse model of Duchenne muscular dystrophy: A reappraisal from sensory to executive processes.
    Chaussenot R; Edeline JM; Le Bec B; El Massioui N; Laroche S; Vaillend C
    Neurobiol Learn Mem; 2015 Oct; 124():111-22. PubMed ID: 26190833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
    Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
    Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of ultrasonography for non-invasive assessment of diaphragm function in muscular dystrophy.
    Whitehead NP; Bible KL; Kim MJ; Odom GL; Adams ME; Froehner SC
    J Physiol; 2016 Dec; 594(24):7215-7227. PubMed ID: 27570057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain function in Duchenne muscular dystrophy.
    Anderson JL; Head SI; Rae C; Morley JW
    Brain; 2002 Jan; 125(Pt 1):4-13. PubMed ID: 11834588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of brain dystrophins absence and impact in dystrophin-deficient Dmdmdx rat model.
    Caudal D; François V; Lafoux A; Ledevin M; Anegon I; Le Guiner C; Larcher T; Huchet C
    PLoS One; 2020; 15(3):e0230083. PubMed ID: 32160266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
    Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
    Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual Discrimination, Serial Reversal, and Extinction Learning in the
    Dickson PE; Mittleman G
    Front Behav Neurosci; 2019; 13():200. PubMed ID: 31543764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.
    van der Pijl EM; van Putten M; Niks EH; Verschuuren JJ; Aartsma-Rus A; Plomp JJ
    Eur J Neurosci; 2016 Jun; 43(12):1623-35. PubMed ID: 27037492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy.
    Harper SQ; Hauser MA; DelloRusso C; Duan D; Crawford RW; Phelps SF; Harper HA; Robinson AS; Engelhardt JF; Brooks SV; Chamberlain JS
    Nat Med; 2002 Mar; 8(3):253-61. PubMed ID: 11875496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of gene expression differences between utrophin/dystrophin-deficient vs mdx skeletal muscles reveals a specific upregulation of slow muscle genes in limb muscles.
    Baker PE; Kearney JA; Gong B; Merriam AP; Kuhn DE; Porter JD; Rafael-Fortney JA
    Neurogenetics; 2006 May; 7(2):81-91. PubMed ID: 16525850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral characterization of mdx3cv mice deficient in C-terminal dystrophins.
    Vaillend C; Ungerer A
    Neuromuscul Disord; 1999 Jul; 9(5):296-304. PubMed ID: 10407849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive dysfunction in Duchenne muscular dystrophy: a possible role for neuromodulatory immune molecules.
    Rae MG; O'Malley D
    J Neurophysiol; 2016 Sep; 116(3):1304-15. PubMed ID: 27385793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
    Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
    Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function.
    Lindsay A; Schmiechen A; Chamberlain CM; Ervasti JM; Lowe DA
    Exp Physiol; 2018 Jul; 103(7):995-1009. PubMed ID: 29791760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Translational Research and Murine Models For Duchenne Muscular Dystrophy.
    Rodrigues M; Echigoya Y; Fukada SI; Yokota T
    J Neuromuscul Dis; 2016 Mar; 3(1):29-48. PubMed ID: 27854202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelination is delayed during postnatal brain development in the mdx mouse model of Duchenne muscular dystrophy.
    Aranmolate A; Tse N; Colognato H
    BMC Neurosci; 2017 Aug; 18(1):63. PubMed ID: 28806929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy.
    Siemionow M; Malik M; Langa P; Cwykiel J; Brodowska S; Heydemann A
    Stem Cell Rev Rep; 2019 Dec; 15(6):827-841. PubMed ID: 31612351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.